ESR1 and chronic myelogenous leukemia, BCR-ABL1 positive: These pathways include “Cell cycle” (p-value = 1.3 × 10−2), “Estrogen receptor signaling” (p-value = 8.0 × 10−3), “mRNA surveillance pathway” (p-value = 2.3 × 10−2), “Ubiquitin mediated proteolysis” (p-value = 1.9 × 10−2), “Longevity regulating pathway—multiple species” (p-value = 1.9 × 10−2), “Chronic myeloid leukemia” (p-value = 8.0 × 10−3), and “Yersinia infection” (p-value = 1.3 × 10−2) (Figure 5, Supplementary Figure S2).